Header Logo

Laurel Habel

Concepts (560)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
85
2024
954
11.040
Why?
Mammography
26
2024
169
4.520
Why?
Neoplasm Recurrence, Local
24
2023
246
3.630
Why?
Carcinoma, Intraductal, Noninfiltrating
12
2020
40
3.420
Why?
Neoplasms
17
2023
444
2.910
Why?
Middle Aged
126
2025
7988
2.830
Why?
Humans
178
2025
17762
2.830
Why?
Breast
16
2023
85
2.820
Why?
Prostatic Neoplasms
15
2020
262
2.710
Why?
Female
142
2025
12740
2.690
Why?
Breast Density
8
2024
31
2.680
Why?
Aged
92
2024
6150
2.170
Why?
Adult
92
2024
7678
2.110
Why?
Hypoglycemic Agents
10
2015
271
1.960
Why?
Risk Factors
64
2024
3356
1.930
Why?
Carcinoma, Ductal, Breast
10
2020
53
1.890
Why?
Biomarkers, Tumor
11
2021
143
1.880
Why?
Case-Control Studies
42
2023
1120
1.780
Why?
Cohort Studies
50
2023
2586
1.770
Why?
California
44
2020
2326
1.610
Why?
Receptor, ErbB-2
8
2023
46
1.530
Why?
Thiazolidinediones
7
2015
52
1.490
Why?
Diabetes Mellitus, Type 2
9
2015
755
1.460
Why?
Aged, 80 and over
35
2024
1923
1.380
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8
2017
172
1.350
Why?
Pancreatic Neoplasms
3
2023
67
1.340
Why?
Genetic Predisposition to Disease
13
2025
375
1.320
Why?
Male
68
2025
10106
1.280
Why?
Adenocarcinoma
9
2023
172
1.280
Why?
Lung Neoplasms
6
2021
260
1.230
Why?
Antineoplastic Agents, Hormonal
7
2020
63
1.210
Why?
Colorectal Neoplasms
6
2017
615
1.210
Why?
Antihypertensive Agents
5
2020
161
1.200
Why?
Women's Health
12
2022
201
1.180
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2016
46
1.140
Why?
Registries
19
2020
472
1.110
Why?
Attention Deficit Disorder with Hyperactivity
5
2011
64
1.070
Why?
Risk
19
2020
517
1.060
Why?
Risk Assessment
19
2020
1101
1.030
Why?
Mastectomy, Segmental
6
2020
20
1.020
Why?
Proportional Hazards Models
22
2022
710
1.020
Why?
Liver Neoplasms
2
2016
40
0.990
Why?
Follow-Up Studies
27
2017
1213
0.940
Why?
Carcinoma
2
2015
22
0.930
Why?
Retrospective Studies
21
2023
2461
0.920
Why?
Drug-Related Side Effects and Adverse Reactions
3
2009
107
0.910
Why?
Incidence
23
2016
1266
0.890
Why?
Urinary Bladder Neoplasms
4
2015
56
0.860
Why?
Smoking
10
2015
483
0.860
Why?
Prognosis
19
2023
609
0.850
Why?
European Continental Ancestry Group
11
2020
529
0.850
Why?
Neoplasm Staging
17
2020
327
0.830
Why?
Menarche
3
2024
28
0.810
Why?
Drug Prescriptions
4
2016
151
0.790
Why?
Central Nervous System Stimulants
4
2011
27
0.790
Why?
Herpes Zoster
2
2014
82
0.790
Why?
Adiposity
2
2024
66
0.760
Why?
Carcinoma in Situ
5
2009
17
0.760
Why?
Neoplasms, Second Primary
4
2022
29
0.720
Why?
Continental Population Groups
9
2017
302
0.720
Why?
Polymorphism, Single Nucleotide
11
2025
379
0.690
Why?
Diabetes Mellitus, Type 1
2
2013
121
0.680
Why?
Odds Ratio
15
2017
671
0.670
Why?
Gene Expression Regulation, Neoplastic
6
2015
51
0.660
Why?
Menopause
6
2011
68
0.650
Why?
Neoplasm Invasiveness
8
2017
78
0.640
Why?
Body Mass Index
14
2015
964
0.620
Why?
Fractures, Bone
1
2019
91
0.610
Why?
Genome-Wide Association Study
10
2025
249
0.610
Why?
Mammary Glands, Human
3
2015
8
0.590
Why?
Alaska Natives
1
2017
5
0.590
Why?
Antidepressive Agents
1
2019
155
0.590
Why?
Reverse Transcriptase Polymerase Chain Reaction
5
2014
27
0.590
Why?
Adolescent
22
2024
3685
0.580
Why?
Neoplasms, Multiple Primary
3
2025
18
0.580
Why?
Indians, North American
1
2017
49
0.580
Why?
Managed Care Programs
2
2010
325
0.570
Why?
Paroxetine
2
2015
23
0.570
Why?
Antidepressive Agents, Second-Generation
2
2015
28
0.570
Why?
Young Adult
16
2024
2461
0.570
Why?
Cost of Illness
2
2009
92
0.560
Why?
Gallbladder
1
2017
1
0.560
Why?
Metformin
3
2015
57
0.560
Why?
Lip Neoplasms
2
2017
2
0.560
Why?
Drug Utilization Review
2
2007
25
0.560
Why?
Hydrochlorothiazide
2
2017
5
0.560
Why?
Cholinergic Antagonists
1
2017
6
0.550
Why?
Legislation, Medical
1
2016
5
0.550
Why?
Homeodomain Proteins
2
2015
16
0.540
Why?
Logistic Models
15
2021
927
0.540
Why?
Phosphodiesterase 5 Inhibitors
1
2016
4
0.540
Why?
Sildenafil Citrate
1
2016
4
0.540
Why?
Disclosure
1
2016
19
0.540
Why?
Child Health Services
2
2009
113
0.540
Why?
Hypercholesterolemia
1
2016
32
0.530
Why?
Immunocompromised Host
2
2014
18
0.530
Why?
Pharmacoepidemiology
3
2023
18
0.530
Why?
Melanoma
1
2016
35
0.520
Why?
Practice Patterns, Physicians'
3
2017
331
0.520
Why?
Magnetic Resonance Imaging
1
2016
106
0.520
Why?
Time Factors
13
2023
1093
0.510
Why?
Receptors, Estrogen
6
2016
51
0.510
Why?
Benzodiazepines
2
2015
29
0.500
Why?
United States
17
2019
4003
0.490
Why?
Body Constitution
3
2007
39
0.490
Why?
Anti-Bacterial Agents
2
2007
141
0.490
Why?
Gene Expression Profiling
5
2023
34
0.490
Why?
C-Reactive Protein
1
2015
59
0.470
Why?
Receptors, Progesterone
7
2023
50
0.470
Why?
Confounding Factors (Epidemiology)
6
2016
86
0.460
Why?
Neuralgia
1
2014
3
0.460
Why?
Exercise
4
2016
492
0.460
Why?
Antineoplastic Agents
5
2023
59
0.460
Why?
Peritoneal Neoplasms
1
2014
2
0.450
Why?
Ovariectomy
1
2014
9
0.450
Why?
Ethnic Groups
8
2017
485
0.450
Why?
Testicular Neoplasms
1
2013
11
0.450
Why?
Fluoxetine
1
2013
26
0.450
Why?
Hysterectomy
1
2014
29
0.450
Why?
Carcinoma, Ductal
2
2011
4
0.450
Why?
Barrett Esophagus
7
2008
114
0.450
Why?
Insulin, Long-Acting
1
2013
11
0.440
Why?
Gonadal Steroid Hormones
4
2017
26
0.440
Why?
Serotonin Uptake Inhibitors
1
2013
71
0.430
Why?
Ovarian Neoplasms
1
2014
49
0.430
Why?
Receptors, Interleukin
1
2013
4
0.430
Why?
Mass Screening
3
2016
677
0.420
Why?
Lymph Nodes
1
2013
17
0.420
Why?
Cardiovascular Diseases
3
2016
599
0.420
Why?
Nifedipine
1
2012
7
0.410
Why?
Tumor Suppressor Protein p53
2
2023
20
0.410
Why?
Stomach Neoplasms
3
2002
41
0.410
Why?
Mendelian Randomization Analysis
2
2024
25
0.410
Why?
Herpesvirus 3, Human
1
2012
44
0.400
Why?
Chemotherapy, Adjuvant
8
2020
73
0.400
Why?
Tamoxifen
4
2016
56
0.400
Why?
Thyroxine
1
2011
4
0.390
Why?
Reproductive History
2
2011
17
0.390
Why?
Data Interpretation, Statistical
2
2011
77
0.390
Why?
In Situ Hybridization, Fluorescence
2
2012
14
0.380
Why?
Breast Neoplasms, Male
3
2015
9
0.370
Why?
Norepinephrine
1
2011
2
0.370
Why?
Alcoholism
1
2015
348
0.370
Why?
Colonic Neoplasms
2
2011
156
0.370
Why?
Breast Diseases
2
2008
18
0.360
Why?
Metabolic Syndrome
1
2011
80
0.350
Why?
Carcinoma, Lobular
3
2012
10
0.350
Why?
Helicobacter Infections
3
2008
22
0.350
Why?
Helicobacter pylori
3
2008
24
0.350
Why?
Longitudinal Studies
6
2015
719
0.350
Why?
Drug Evaluation, Preclinical
1
2009
4
0.340
Why?
Physical Fitness
1
2010
73
0.340
Why?
Pharmaceutical Preparations
1
2009
11
0.340
Why?
Tobacco Smoke Pollution
1
2010
34
0.340
Why?
Combined Modality Therapy
3
2020
145
0.340
Why?
SEER Program
5
2016
91
0.340
Why?
Mutation
3
2023
130
0.330
Why?
Age Distribution
6
2012
246
0.320
Why?
Antibodies, Monoclonal, Humanized
3
2014
24
0.320
Why?
Transcriptome
3
2025
25
0.320
Why?
Maternal Welfare
1
2009
14
0.320
Why?
Precancerous Conditions
3
2008
47
0.320
Why?
Colonoscopy
2
2008
253
0.320
Why?
Asian Continental Ancestry Group
5
2017
90
0.310
Why?
Early Detection of Cancer
5
2023
513
0.310
Why?
Disabled Children
1
2009
28
0.310
Why?
Methylphenidate
1
2007
4
0.300
Why?
Hypertension
3
2020
504
0.300
Why?
Sentinel Surveillance
1
2007
12
0.300
Why?
Treatment Outcome
7
2020
1260
0.300
Why?
Mothers
1
2009
105
0.290
Why?
Colonic Polyps
1
2007
35
0.290
Why?
Dairy Products
1
2007
22
0.280
Why?
Child
8
2024
2491
0.280
Why?
Anti-Inflammatory Agents, Non-Steroidal
3
2007
65
0.280
Why?
Cholesterol
2
2017
106
0.270
Why?
Mental Health Services
1
2009
159
0.270
Why?
Pathology, Clinical
2
2010
14
0.270
Why?
Health Care Costs
1
2009
229
0.270
Why?
Aspirin
2
2007
63
0.260
Why?
Selective Estrogen Receptor Modulators
1
2006
11
0.260
Why?
Raloxifene Hydrochloride
1
2006
12
0.260
Why?
Estrogen Replacement Therapy
5
2008
99
0.260
Why?
Antibodies, Viral
3
2024
65
0.260
Why?
Blood Glucose
1
2008
343
0.250
Why?
Asthma
1
2009
385
0.250
Why?
Electronic Health Records
5
2015
697
0.250
Why?
Condylomata Acuminata
4
1998
23
0.250
Why?
Denmark
4
2020
18
0.250
Why?
Alcohol Drinking
4
2020
373
0.250
Why?
Age Factors
11
2016
918
0.250
Why?
State Health Plans
1
2005
35
0.240
Why?
Recurrence
6
2023
188
0.240
Why?
Spike Glycoprotein, Coronavirus
1
2024
4
0.230
Why?
Radiotherapy, Adjuvant
2
2017
18
0.230
Why?
Life Style
5
2016
333
0.230
Why?
Confidence Intervals
6
2016
237
0.230
Why?
Algorithms
5
2023
239
0.230
Why?
Dose-Response Relationship, Drug
4
2017
129
0.220
Why?
Diuretics
2
2017
17
0.220
Why?
Postmenopause
5
2011
242
0.220
Why?
Antigens, Bacterial
2
2007
8
0.220
Why?
Bacterial Proteins
2
2007
13
0.220
Why?
Proto-Oncogene Proteins p21(ras)
1
2023
21
0.220
Why?
Socioeconomic Factors
4
2020
630
0.210
Why?
Anti-Mullerian Hormone
1
2022
2
0.200
Why?
Prospective Studies
10
2020
1279
0.200
Why?
Surveys and Questionnaires
7
2016
1321
0.200
Why?
Estrogen Receptor alpha
4
2015
25
0.200
Why?
Prevalence
5
2017
886
0.200
Why?
Calcium Channel Blockers
2
2020
14
0.200
Why?
Genetic Testing
3
2017
71
0.190
Why?
Survival Rate
3
2017
260
0.190
Why?
Carcinoma, Squamous Cell
2
2017
55
0.180
Why?
Comorbidity
2
2017
597
0.180
Why?
Sensitivity and Specificity
3
2015
304
0.180
Why?
Sexual Behavior
3
1998
124
0.180
Why?
African Americans
4
2015
472
0.180
Why?
Molecular Epidemiology
1
2021
44
0.180
Why?
Multifactorial Inheritance
1
2020
20
0.180
Why?
Sleep Wake Disorders
1
2021
37
0.180
Why?
Carcinoma, Renal Cell
1
2020
10
0.180
Why?
Kidney Neoplasms
1
2020
16
0.180
Why?
Carcinogenesis
1
2020
9
0.180
Why?
Cross-Sectional Studies
4
2024
1330
0.180
Why?
Data Collection
2
2012
256
0.180
Why?
Premenopause
4
2022
24
0.180
Why?
Linear Models
3
2011
231
0.180
Why?
Hair
1
2000
7
0.180
Why?
Face
1
2000
5
0.180
Why?
Gastroesophageal Reflux
4
2008
79
0.170
Why?
Regional Medical Programs
1
2020
2
0.170
Why?
Depression
2
2015
505
0.170
Why?
Health Maintenance Organizations
6
2009
417
0.170
Why?
Prostate-Specific Antigen
3
2017
75
0.170
Why?
Heart Failure
3
2016
396
0.170
Why?
Child, Preschool
4
2011
1419
0.170
Why?
Multivariate Analysis
5
2015
568
0.170
Why?
Tobacco Smoking
1
2020
20
0.170
Why?
Trastuzumab
3
2014
14
0.170
Why?
Health Plan Implementation
1
2020
36
0.170
Why?
Anthropometry
2
2017
66
0.170
Why?
Protective Factors
2
2016
32
0.170
Why?
Delivery of Health Care, Integrated
4
2017
535
0.170
Why?
Reproducibility of Results
4
2015
381
0.170
Why?
Barbiturates
1
1999
1
0.170
Why?
Abdominal Fat
2
2011
14
0.160
Why?
Immunoenzyme Techniques
3
2014
20
0.160
Why?
Behavior
2
2017
18
0.160
Why?
Accidental Falls
1
2019
38
0.160
Why?
RNA, Messenger
3
2014
72
0.160
Why?
Neoplasm Grading
3
2014
48
0.160
Why?
Phenobarbital
1
1998
2
0.160
Why?
Esophageal Neoplasms
5
2008
115
0.160
Why?
Drug Utilization
2
2017
128
0.160
Why?
Propensity Score
1
2019
85
0.160
Why?
Aging
1
2000
162
0.160
Why?
Telemedicine
1
2022
186
0.160
Why?
Hypnotics and Sedatives
1
1998
18
0.160
Why?
Parity
2
2010
74
0.160
Why?
Kaplan-Meier Estimate
3
2014
129
0.160
Why?
Biomarkers
3
2015
303
0.150
Why?
Osteoporosis
1
2019
75
0.150
Why?
Genital Diseases, Female
1
1998
9
0.150
Why?
Organizations, Nonprofit
2
2009
11
0.150
Why?
Lymphoma
1
2017
6
0.150
Why?
Bone Density
3
2007
92
0.150
Why?
Quality Improvement
1
2020
194
0.150
Why?
Datasets as Topic
1
2017
20
0.150
Why?
Biopsy
3
2009
75
0.150
Why?
Disease-Free Survival
2
2015
57
0.150
Why?
Blood Pressure
1
2019
302
0.140
Why?
Bias
3
2023
102
0.140
Why?
Sigmoidoscopy
2
2007
65
0.140
Why?
Multiple Myeloma
1
2017
9
0.140
Why?
African Continental Ancestry Group
3
2017
162
0.140
Why?
Databases, Factual
4
2017
315
0.140
Why?
Rosacea
2
2007
3
0.140
Why?
Immunohistochemistry
2
2014
44
0.140
Why?
Acne Vulgaris
2
2007
8
0.140
Why?
Social Class
1
2017
121
0.140
Why?
Specimen Handling
1
2017
20
0.140
Why?
Adrenergic beta-Antagonists
2
2022
43
0.140
Why?
Medication Adherence
1
2020
245
0.140
Why?
Washington
5
1998
382
0.140
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2016
2
0.140
Why?
Child Health
1
2017
35
0.140
Why?
Proto-Oncogene Proteins B-raf
1
2016
15
0.140
Why?
Neoplasm Proteins
1
2016
9
0.140
Why?
Genetic Loci
1
2017
55
0.140
Why?
Aspartate Aminotransferases
1
2016
13
0.130
Why?
Causality
1
2016
40
0.130
Why?
Research
1
2017
65
0.130
Why?
Predictive Value of Tests
3
2015
354
0.130
Why?
Tumor Burden
2
2013
19
0.130
Why?
Alanine Transaminase
1
2016
21
0.130
Why?
Research Design
3
2015
376
0.130
Why?
Child Development
1
2017
54
0.130
Why?
Contraceptives, Oral
1
1996
26
0.130
Why?
Metabolic Equivalent
1
2016
8
0.130
Why?
Diabetes Mellitus
3
2010
487
0.130
Why?
Outcome Assessment (Health Care)
1
2017
228
0.130
Why?
Pregnancy
5
2010
1524
0.130
Why?
Insulin-Like Growth Factor I
1
2016
13
0.130
Why?
Motor Activity
2
2015
212
0.130
Why?
Polymerase Chain Reaction
2
2012
49
0.130
Why?
Anthracyclines
2
2012
14
0.130
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
86
0.130
Why?
Breast Feeding
2
2015
137
0.130
Why?
Nomograms
1
2015
11
0.120
Why?
Pathology Department, Hospital
1
2015
3
0.120
Why?
Women, Working
1
1995
6
0.120
Why?
Obesity
2
2015
842
0.120
Why?
Diphosphonates
1
2016
63
0.120
Why?
Estrogens
3
2010
61
0.120
Why?
Occupational Diseases
1
1995
41
0.120
Why?
Inflammation
1
2015
63
0.120
Why?
Molecular Targeted Therapy
1
2014
6
0.120
Why?
Cardiomyopathies
1
2014
10
0.110
Why?
Proteinuria
1
2014
26
0.110
Why?
Insurance Claim Review
1
2014
61
0.110
Why?
Insulin Glargine
1
2013
9
0.110
Why?
Reference Values
2
2012
92
0.110
Why?
Carcinoma, Basal Cell
1
2014
24
0.110
Why?
Real-Time Polymerase Chain Reaction
1
2013
12
0.110
Why?
Stroke
2
2016
315
0.110
Why?
Hematologic Neoplasms
1
2012
7
0.100
Why?
Residence Characteristics
1
2015
250
0.100
Why?
Hormones
2
2015
14
0.100
Why?
Estradiol
2
2015
23
0.100
Why?
Patient Acceptance of Health Care
1
2016
390
0.100
Why?
Sex Distribution
1
2012
190
0.100
Why?
Cyclohexanecarboxylic Acids
1
2011
4
0.100
Why?
Amines
1
2011
5
0.100
Why?
gamma-Aminobutyric Acid
1
2011
5
0.100
Why?
Anticonvulsants
1
2011
9
0.100
Why?
Phenotype
2
2022
151
0.100
Why?
Iron
2
2008
16
0.100
Why?
Death, Sudden, Cardiac
1
2011
35
0.100
Why?
Menstruation
1
2011
7
0.090
Why?
Sulfonylurea Compounds
2
2010
25
0.090
Why?
Densitometry
1
2011
1
0.090
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
50
0.090
Why?
Prazosin
1
2011
1
0.090
Why?
Clonidine
1
2011
3
0.090
Why?
Propranolol
1
2011
4
0.090
Why?
Metoprolol
1
2011
6
0.090
Why?
Atenolol
1
2011
8
0.090
Why?
Perimenopause
2
2009
11
0.090
Why?
Adipose Tissue
2
2009
58
0.090
Why?
Health Services Research
1
2012
231
0.090
Why?
Dietary Supplements
1
2011
87
0.090
Why?
Chromosomes, Human, Pair 17
1
2010
3
0.090
Why?
False Negative Reactions
1
2010
12
0.090
Why?
Vitamins
1
2011
64
0.090
Why?
False Positive Reactions
1
2010
26
0.090
Why?
Laboratories
1
2010
18
0.090
Why?
Insulin
2
2010
206
0.090
Why?
Age of Onset
2
2007
79
0.090
Why?
Medical Audit
1
2010
38
0.090
Why?
Estrogen Antagonists
1
2010
3
0.090
Why?
Massachusetts
1
2010
93
0.090
Why?
Fetus
1
1990
6
0.090
Why?
Narcotics
1
1990
7
0.090
Why?
Carcinogenicity Tests
1
2009
2
0.090
Why?
Carcinogens
1
2009
3
0.090
Why?
Maternal-Fetal Exchange
1
1990
13
0.090
Why?
Infant Mortality
1
1990
20
0.090
Why?
Myocardial Infarction
1
2011
238
0.080
Why?
Diabetes Complications
1
2010
114
0.080
Why?
Glycated Hemoglobin A
1
2010
216
0.080
Why?
Adenoma
1
2010
93
0.080
Why?
Substance-Related Disorders
2
1993
434
0.080
Why?
Ligands
1
2008
6
0.080
Why?
Ferritins
1
2008
9
0.080
Why?
Antiprotozoal Agents
1
2008
2
0.080
Why?
Furosemide
1
2008
2
0.080
Why?
Griseofulvin
1
2008
2
0.080
Why?
Metronidazole
1
2008
4
0.080
Why?
Antifungal Agents
1
2008
4
0.080
Why?
Hemochromatosis
1
2008
7
0.080
Why?
Histocompatibility Antigens Class I
1
2008
7
0.080
Why?
Neoplasms, Hormone-Dependent
1
2008
8
0.080
Why?
Pennsylvania
1
2008
25
0.080
Why?
Delivery of Health Care
1
2012
415
0.080
Why?
Glycemic Index
1
2008
20
0.070
Why?
Membrane Proteins
1
2008
39
0.070
Why?
Lovastatin
1
2008
7
0.070
Why?
Amphetamines
1
2007
2
0.070
Why?
Leukemia, Lymphoid
1
2007
2
0.070
Why?
Pemoline
1
2007
2
0.070
Why?
Genomics
2
2020
55
0.070
Why?
Clinical Pharmacy Information Systems
1
2007
10
0.070
Why?
Simvastatin
1
2008
11
0.070
Why?
Thyroid Neoplasms
1
2007
11
0.070
Why?
Randomized Controlled Trials as Topic
2
2011
328
0.070
Why?
Insurance Carriers
1
2007
6
0.070
Why?
Ibuprofen
1
2007
9
0.070
Why?
Tetracyclines
1
2006
2
0.070
Why?
Patient Compliance
1
2009
300
0.070
Why?
Macrolides
1
2006
7
0.070
Why?
Risk Adjustment
1
2006
24
0.070
Why?
Esophageal Sphincter, Lower
1
2006
3
0.070
Why?
Prepaid Health Plans
1
2006
20
0.070
Why?
Survivors
3
2015
149
0.070
Why?
Deductibles and Coinsurance
1
2006
30
0.070
Why?
Alleles
2
2017
85
0.070
Why?
Single-Blind Method
1
2004
44
0.060
Why?
Seroepidemiologic Studies
1
2024
18
0.060
Why?
Glioma
1
2004
5
0.060
Why?
Weight Gain
1
2006
173
0.060
Why?
Brain Neoplasms
1
2004
15
0.060
Why?
Body Size
1
2024
31
0.060
Why?
Health Status
1
2006
298
0.060
Why?
International Cooperation
2
2015
17
0.060
Why?
Health Behavior
1
2006
360
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2006
382
0.050
Why?
Mastectomy
1
2023
36
0.050
Why?
HIV Infections
1
2009
696
0.050
Why?
Artificial Intelligence
1
2023
21
0.050
Why?
Whole Exome Sequencing
1
2022
8
0.050
Why?
Exome
1
2022
21
0.050
Why?
Vaccination
2
2024
655
0.050
Why?
Multicenter Studies as Topic
2
2012
86
0.050
Why?
Sudden Infant Death
2
1993
10
0.050
Why?
Mental Disorders
1
2005
280
0.050
Why?
Skin Neoplasms
1
2002
57
0.050
Why?
Hispanic Americans
2
2015
404
0.050
Why?
Survival Analysis
2
2012
215
0.050
Why?
Prescriptions
1
2021
27
0.050
Why?
Observer Variation
1
2001
37
0.050
Why?
Epidemiologic Studies
1
2001
29
0.050
Why?
Sleep
1
2021
58
0.050
Why?
Genetic Pleiotropy
1
2020
9
0.050
Why?
Genotype
1
2021
227
0.040
Why?
Body Height
1
2000
62
0.040
Why?
Diet
2
2010
365
0.040
Why?
Pandemics
1
2022
287
0.040
Why?
Sex Factors
3
2010
644
0.040
Why?
Angiotensin Receptor Antagonists
1
2020
53
0.040
Why?
San Francisco
1
1999
64
0.040
Why?
Acquired Immunodeficiency Syndrome
2
1990
63
0.040
Why?
Epidemiologic Methods
1
1999
81
0.040
Why?
Genital Diseases, Male
1
1998
2
0.040
Why?
Double-Blind Method
2
2008
155
0.040
Why?
Oncologists
1
2017
7
0.040
Why?
Gene Frequency
1
2017
43
0.030
Why?
Gene Expression
1
2017
23
0.030
Why?
Prostate
1
2017
28
0.030
Why?
Morbidity
1
2017
59
0.030
Why?
Feasibility Studies
1
2017
114
0.030
Why?
Multigene Family
1
2016
7
0.030
Why?
Body Weight
2
2009
223
0.030
Why?
Drug Carriers
1
2016
1
0.030
Why?
Pathology, Molecular
1
2016
1
0.030
Why?
Heart Valve Diseases
1
2016
20
0.030
Why?
Drug Approval
1
2016
12
0.030
Why?
Pilot Projects
1
2017
218
0.030
Why?
Arrhythmias, Cardiac
1
2016
32
0.030
Why?
Administration, Oral
1
2016
85
0.030
Why?
Health Resources
1
2015
37
0.030
Why?
Capsid
1
1995
1
0.030
Why?
INDEL Mutation
1
2015
7
0.030
Why?
Progestins
1
1995
25
0.030
Why?
Androgens
1
2015
12
0.030
Why?
Cell Proliferation
1
2015
19
0.030
Why?
Quantitative Trait Loci
1
2015
38
0.030
Why?
Phylogeny
1
2015
14
0.030
Why?
Germ-Line Mutation
1
2015
18
0.030
Why?
Papillomaviridae
1
1995
58
0.030
Why?
Haplotypes
1
2015
34
0.030
Why?
Coronary Artery Disease
1
2016
134
0.030
Why?
Tobacco
1
2014
14
0.030
Why?
Guideline Adherence
1
2016
157
0.030
Why?
Chi-Square Distribution
2
2011
154
0.030
Why?
Radiotherapy Dosage
1
2014
3
0.030
Why?
Clinical Coding
1
2014
11
0.030
Why?
Utah
1
2014
33
0.030
Why?
New York City
2
1993
21
0.030
Why?
Heroin
1
1993
5
0.030
Why?
Cocaine
1
1993
6
0.030
Why?
Methadone
1
1993
10
0.030
Why?
Stroke Volume
1
2014
100
0.030
Why?
Taxoids
1
2012
8
0.030
Why?
Lymphatic Metastasis
1
2012
29
0.030
Why?
Antibiotics, Antineoplastic
1
2012
7
0.030
Why?
ROC Curve
1
2012
77
0.020
Why?
United Kingdom
1
2011
30
0.020
Why?
Health Personnel
1
2012
125
0.020
Why?
Prenatal Exposure Delayed Effects
1
1993
167
0.020
Why?
Infant, Newborn
2
1993
855
0.020
Why?
Patient Selection
1
2012
190
0.020
Why?
Clinical Trials as Topic
1
2011
132
0.020
Why?
Health Status Disparities
1
2012
146
0.020
Why?
Incretins
1
2010
2
0.020
Why?
Receptor, Insulin
1
2010
6
0.020
Why?
Receptor, IGF Type 1
1
2010
5
0.020
Why?
Hyperinsulinism
1
2010
9
0.020
Why?
Practice Guidelines as Topic
1
2012
321
0.020
Why?
Self Report
1
2012
253
0.020
Why?
Testosterone
1
2010
22
0.020
Why?
Cytokines
1
2010
30
0.020
Why?
Factor VIII
1
1990
2
0.020
Why?
Transfusion Reaction
1
1990
2
0.020
Why?
Factor IX
1
1990
3
0.020
Why?
Healthcare Disparities
1
2012
203
0.020
Why?
Cytochrome P-450 CYP1B1
1
2009
2
0.020
Why?
17-Hydroxysteroid Dehydrogenases
1
2009
3
0.020
Why?
HIV-1
1
1990
70
0.020
Why?
Cytochrome P-450 CYP1A1
1
2009
6
0.020
Why?
Aromatase
1
2009
7
0.020
Why?
Aryl Hydrocarbon Hydroxylases
1
2009
6
0.020
Why?
Estrogen Receptor beta
1
2009
10
0.020
Why?
Cytochrome P-450 Enzyme System
1
2009
8
0.020
Why?
Cause of Death
1
1990
181
0.020
Why?
Iron, Dietary
1
2008
7
0.020
Why?
Esophagoscopy
1
2008
19
0.020
Why?
Hemochromatosis Protein
1
2008
7
0.020
Why?
Homozygote
1
2008
13
0.020
Why?
Heterozygote
1
2008
26
0.020
Why?
Hyperplasia
1
2008
6
0.020
Why?
Overweight
1
2010
269
0.020
Why?
Men's Health
1
2007
20
0.020
Why?
Antibodies, Bacterial
1
2007
33
0.020
Why?
Drug Administration Schedule
1
2007
98
0.020
Why?
Fertility Agents, Female
1
2007
2
0.020
Why?
Hip
1
2007
9
0.020
Why?
Contraceptives, Oral, Hormonal
1
2007
12
0.020
Why?
Lumbar Vertebrae
1
2007
19
0.020
Why?
Thigh
1
2007
11
0.020
Why?
Waist-Hip Ratio
1
2007
23
0.020
Why?
Chemoprevention
1
2007
12
0.020
Why?
Education, Medical, Continuing
1
2007
30
0.020
Why?
Osteoporosis, Postmenopausal
1
2007
42
0.020
Why?
Secondary Prevention
1
2007
48
0.020
Why?
Muscle Relaxation
1
2006
3
0.020
Why?
Xanthines
1
2006
6
0.020
Why?
Nitrates
1
2006
8
0.020
Why?
Adrenergic beta-Agonists
1
2006
33
0.020
Why?
Anti-Asthmatic Agents
1
2006
85
0.020
Why?
Risk-Taking
1
2006
109
0.020
Why?
Rubella Vaccine
1
1985
8
0.020
Why?
Health Surveys
1
2006
260
0.020
Why?
Endoscopy, Digestive System
1
2002
10
0.010
Why?
Vaccinia virus
1
1995
1
0.010
Why?
Genetic Vectors
1
1995
2
0.010
Why?
DNA Primers
1
1995
7
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1995
17
0.010
Why?
Base Sequence
1
1995
19
0.010
Why?
Molecular Sequence Data
1
1995
18
0.010
Why?
Drug Therapy, Combination
1
1995
114
0.010
Why?
Vitamin A
1
1994
14
0.010
Why?
Ascorbic Acid
1
1994
19
0.010
Why?
Urban Population
1
1993
116
0.010
Why?
Hot Temperature
1
1990
8
0.010
Why?
HIV Seropositivity
1
1990
31
0.010
Why?
Infant
1
1993
1192
0.010
Why?
Rubella
1
1985
6
0.000
Why?
Disease Outbreaks
1
1985
36
0.000
Why?
Immunization
1
1985
70
0.000
Why?
Concepts (560)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente